Acta Scientific Neurology (ASNE) (ISSN: 2582-1121)

Research Article Volume 5 Issue 10

Role of rTMS and Expression Levels of Serum Growth Factors Along with Neurophysiological Markers in Ischemic Stroke Recovery: A Double Blind, Parallel Group, Sham Controlled Randomized Study

Sharma H1, Kumar N2, Sreenivas V3, Rajeswari MR4 and Srivastava M V Padma 1*

1Department of Neurology, All-India Institutes of Medical Sciences, New Delhi, India
2Department of Psychiatry, All-India Institutes of Medical Sciences, New Delhi, India
3Department of Biostatistics, All-India Institutes of Medical Sciences, New Delhi, India
4Department of Biochemistry, All-India Institutes of Medical Sciences, New Delhi, India

*Corresponding Author:Srivastava M V Padma, Department of Neurology, All-India Institutes of Medical Sciences, New Delhi, India.

Received: June 30, 2022; Published: September 20, 2022


Background: The therapeutic benefits and efficacy of repetitive trans cranial magnetic stimulation along with physical therapy in exerting the cellular and molecular aspects, and changes in neurophysiological markers during the functional recovery in ischemic stroke patients have not been fully elucidated. The aim of this study is to determine the role of serum growth factors levels as a surrogate marker, using 1Hz rTMS with conventional physiotherapy in patients with ischemic stroke.

Methods: Study participants with first ever ischemic stroke (N = 96), onset within 15 days were randomized after a run-in period of 75 ± 7 days along with standard physical therapy to receive 10 sessions of real 1Hz rTMS (N = 47) on contra lesion premotor cortex or to sham stimulation (N = 49) for 2 weeks. Participants, investigators and outcome assessors were blinded. The study outcomes were to measure changes in the expression levels of peripheral serum growth factors VEGF and BDNF and neurophysiological changes at third month.

Results: Modified intention to treat analysis showed significant up regulation in the mean levels of serum VEGF (797.24 ± 224.27) and BDNF (30.64 ± 9.64), P < 0.001 in Real rTMS Group. Trend of decrease in Resting Motor Threshold and an increase in Motor Evoked Potential in the affected hand was observed. Statistically significant negative correlation between motor evoked potential and mean VEGF (rho = -1.000, P < 0.001) in the affected hand in Real rTMS Group was seen.

Conclusion: Total ten sessions of 1Hz rTMS plus physical therapy on contralateral hemisphere resulted in up regulation of serum growth factors possible reflecting improved neuroplasticity.

Keywords: Ischemic Stroke; Transcranial Magnetic Stimulation; Serum Growth Factors; Motor Threshold; Motor Evoked Potential


  1. Sobrino T., et al. “Association of High Serum Levels of Growth Factors with Good Outcome in Ischemic Stroke: a Multicenter Study”. Translational Stroke Research 4 (2020): 653-663.
  2. Fisicaro F., et al. “Repetitive transcranial magnetic stimulation in stroke rehabilitation: review of the current evidence and pitfalls”. Therapeutic Advances in Neurological Disorders 12 (2019): 1756286419878317.
  3. Hsu WY., et al. “Effects of repetitive transcranial magnetic stimulation on motor functions in patients with stroke: A meta-analysis”. Stroke7 (2012): 1849-1857.
  4. Le Q., et al. “Effects of repetitive transcranial magnetic stimulation on hand function recovery and excitability of the motor cortex after stroke: A meta-analysis”. American Journal of Physical Medicine and Rehabilitation 5 (2014): 422-430.
  5. León Ruiz M., et al. “Current evidence on transcranial magnetic stimulation and its potential usefulness in post-stroke neurorehabilitation: Opening new doors to the treatment of cerebrovascular disease”. Neurologia7 (2018): 459-472.
  6. Ploughman M., et al. “The Effects of Poststroke Aerobic Exercise on Neuroplasticity: A Systematic Review of Animal and Clinical Studies”. Translational Stroke Research 1 (2014): 13-28.
  7. Nudo RJ. “Recovery after brain injury: Mechanisms and principles”. Frontiers in Human Neuroscience 7 (2013): 887.
  8. Chan SJ., et al. “Endogenous regeneration: Engineering growth factors for stroke”. Neurochemistry International 107 (2017): 57-65.
  9. Huang X., et al. “Granulocyte colony stimulating factor therapy for stroke: A pairwise meta-analysis of randomized controlled trial”. PLoS One4 (2017): e0175774.
  10. Cichoń N., et al. “Increase in blood levels of growth factors involved in the neuroplasticity process by using an extremely low frequency electromagnetic field in post-stroke patients”. Frontiers in Aging Neuroscience 10 (2018): 294.
  11. Cramer SC. “Repairing the human brain after stroke: I. Mechanisms of spontaneous recovery”. Annals of Neurology 3 (2008): 272-287.
  12. Sharma H., et al. “Efficacy of Low-Frequency Repetitive Transcranial Magnetic Stimulation in Ischemic Stroke: A Double-Blind Randomized Controlled Trial”. Archives of Rehabilitation Research and Clinical Translation 1 (2020): 100039.
  13. Khedr EM. “Therapeutic trial of repetitive transcranial magnetic stimulation after acute ischemic stroke”. Neurology 65 (2005): 466-468.
  14. Rossi S., et al. “Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research”. Clinical Neurophysiology 12 (2009): 2008-2039.
  15. Slevin M., et al. “Serial Measurement of Vascular Endothelial Growth Factor and Transforming Growth Factor- 1 in Serum of Patients With Acute Ischemic Stroke”. Stroke8 (2000): 1863-1870.
  16. Sobrino T., et al. “Temporal profile of molecular signatures associated with circulating endothelial progenitor cells in human ischemic stroke”. Journal of Neuroscience Research 9 (2012): 1788-1793.
  17. Sun Y., et al. “VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia”. Journal of Clinical Investigation 12 (2003): 1843-1851.
  18. Heissig B., et al. “Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of Kit-ligand”. Cell5 (2002): 625-637.
  19. Lee S., et al. “Serum VEGF levels in acute ischaemic strokes are correlated with long-term prognosis (2010): 45-51.
  20. Baba T., et al. “Electrical stimulation of the cerebral cortex exerts antiapoptotic, angiogenic, and anti-inflammatory effects in ischemic stroke rats through phosphoinositide 3-kinase/akt signaling pathway”. Stroke11 (2009): e598-605.
  21. Alsina B., et al. “Visualizing synapse formation in arborizing optic axons in vivo: Dynamics and modulation by BDNF”. Nature Neuroscience 11 (2001): 1093-1101.
  22. Lessmann V., et al. “Neurotrophin secretion: Current facts and future prospects”. Progress in Neurobiology 5 (2003): 341-374.
  23. Qiao H-J., et al. “Association of lower serum Brain-derived neurotrophic factor levels with larger infarct volumes in acute ischemic stroke”. Journal of Neuroimmunology 307 (2017): 69-73.
  24. Yukimasa T., et al. “High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors”. Pharmacopsychiatry2 (2006): 52-59.
  25. Zanardini R., et al. “Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients”. Journal of Affective Disorders 1 (2006): 83-86.
  26. Wang HY., et al. “Repetitive transcranial magnetic stimulation enhances BDNF-TrkB signaling in both brain and lymphocyte”. Journal of Neuroscience 30 (2011): 11044-11054.
  27. Niimi M., et al. “Role of brain-derived neurotrophic factor in beneficial effects of repetitive transcranial magnetic stimulation for upper limb hemiparesis after stroke”. PLoS One3 (2016).
  28. Pikula A., et al. “Serum Brain - Derived Neurotrophic Factor and Vascular endothelial growth factor levels are associated with risk of stroke and vascular brain injury: Framingham Study”. Stroke 10 (2013): 2768-2775.
  29. Hendricks HT., et al. “Analysis of recovery processes after stroke by means of transcranial magnetic stimulation”. In: Journal of Clinical Neurophysiology3 (2003): 188-195.
  30. Van Den Bos MAJ., et al. “Physiological processes influencing motor-evoked potential duration with voluntary contraction”. Journal of Neurophysiology 117 (2017): 1156-1162.
  31. Brum M., et al. “Clinical value of the assessment of changes in MEP duration with voluntary contraction”. Frontiers in Neuroscience (2016).
  32. Zhang L., et al. “Low-Frequency Repetitive Transcranial Magnetic Stimulation for Stroke-Induced Upper Limb Motor Deficit: A Meta-Analysis”. Neural Plasticity 2017 (2017): 2758097.
  33. Hallett M. “Transcranial Magnetic Stimulation: A Primer”. Neuron2 (2007): 187-189.
  34. Fregni F., et al. “A sham-controlled trial of a 5-day course of repetitive transcranial magnetic stimulation of the unaffected hemisphere in stroke patients”. Stroke8 (2006): 2115-2122.
  35. Sung WH., et al. “Efficacy of coupling inhibitory and facilitatory repetitive transcranial magnetic stimulation to enhance motor recovery in hemiplegic stroke patients”. Stroke 5 (2013): 1375-1382.
  36. Wang CP., et al. “Differential Effect of Conditioning Sequences in Coupling Inhibitory/Facilitatory Repetitive Transcranial Magnetic Stimulation for PostStroke Motor Recovery”. CNS Neuroscience and Therapeutics 4 (2014): 355-363.
  37. Du J., et al. “Effects of repetitive transcranial magnetic stimulation on motor recovery and motor cortex excitability in patients with stroke: a randomized controlled trial”. European Journal of Neurology 11 (2016): 1666-1672.
  38. Sasaki N., et al. “Comparison of the effects of high- and low-frequency repetitive transcranial magnetic stimulation on upper limb hemiparesis in the early phase of stroke”. Journal of Stroke and Cerebrovascular Diseases 22 (2013): 413-418.
  39. Cramer SC. “Repairing the human brain after stroke: I. Mechanisms of spontaneous recovery”. Annals of Neurology 63 (2008): 272-287.
  40. Blesneag AV., et al. “Low-frequency rTMS in patients with subacute ischemic stroke: clinical evaluation of short and long-term outcomes and neurophysiological assessment of cortical excitability”. Journal of Medicine and Life 8 (2015): 378-387.


Citation: Srivastava Padma., et al. “Role of rTMS and Expression Levels of Serum Growth Factors Along with Neurophysiological Markers in Ischemic Stroke Recovery: A Double Blind, Parallel Group, Sham Controlled Randomized Study”. Acta Scientific Neurology 5.10 (2022): 33-47.


Copyright: © 2022 Srivastava Padma., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate32%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 20, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US